Clinical Trial Update: An Open Trial to Assess the Tolerability of AVANZ® Salsola Immunotherapy [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 open trial evaluating the tolerability of AVANZ Salsola Immunotherapy for allergic rhinoconjunctivitis due to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinoconjunctivitis Due to Salsola Kali Pollen

Drugs mentioned

• AVANZ Salsola Immunotherapy

Snippet

Sponsor: ALK-Abelló A/S | Conditions: Allergic Rhinoconjunctivitis Due to Salsola Kali Pollen | Phase 2 | Status: COMPLETED